Dr. Philip Bach Vutien, MD

Dr. Vutien practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Vutien's NPI, 1548609548, was assigned on June 24, 2013. Dr. Vutien graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2013. Dr. Vutien holds Washington license MD60751113.

Dr. Vutien's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Vutien's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Dr. Vutien is also affiliated with Olympic Memorial Hospital. The medical group on file is UW Physicians. Dmand AI also links Dr. Vutien to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vutien practices, 4 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Vutien's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Vutien is licensed in Washington.

CMS data shows 164 Medicare services from Dr. Vutien across 7 procedure codes in 2024, for 116 Medicare patients. Medicare paid $16,151 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Dr. Vutien in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vutien's median patient age at 61, with 49% women.

In 2024, Dr. Vutien wrote 412 Medicare Part D claims for 163 patients. 79% of them were for generic drugs. CMS names the drug for 329 of them, across 13 drugs with 11 or more claims each, at $111,472 in total drug cost. In 2023, CMS named 171 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Vutien for performance year 2024, reported through an alternative payment model (APM). Dr. Vutien accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vutien as offering telehealth. CMS counts 22 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Vutien, more than 51% of the clinicians it reports for that procedure.

Dmand AI links 44 papers to Dr. Vutien, published from 2013 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Liver Neoplasms, Carcinoma, Hepatocellular and Antiviral Agents. Dr. Vutien has published most often in Aliment Pharmacol Ther. Dr. Vutien's most frequent co-authors are George Ioannou, MD, Nicole Jung-Eun Kim and Mindie Hoai Nguyen, MD.

CMS Open Payments shows 1 general payment to Dr. Vutien from 1 drug or device company in 2016. Travel and lodging make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $1,277.

Dr. Vutien graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2013.